A. Regdos

Could selected gut microorganisms be diagnostic biomarkers for autism spectrum disorders? Study based on a commercial microbiota test

M. Andrusiewicz, M. Kotwicka, M. Jendraszak, 2021 .

Impact of Biometric Patient Data, Probiotic Supplementation, and Selected Gut Microorganisms on Calprotectin, Zonulin, and sIgA Concentrations in the Stool of Adults Aged 18–74 Years

A. Schwiertz, M. Andrusiewicz, M. Kotwicka, 2022, Biomolecules.

Commercial microbiota test revealed differences in the composition of intestinal microorganisms between children with autism spectrum disorders and neurotypical peers

M. Andrusiewicz, M. Kotwicka, M. Jendraszak, 2021, Scientific Reports.